Processa Pharmaceuticals (PCSA) Stock Forecast, Price Target & Predictions
PCSA Stock Forecast
Processa Pharmaceuticals stock forecast is as follows: an average price target of $9.00 (represents a 922.73% upside from PCSA’s last price of $0.88) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
PCSA Price Target
PCSA Analyst Ratings
Buy
Processa Pharmaceuticals Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Apr 19, 2022 | - | Maxim Group | $9.00 | $3.18 | 182.62% | 922.73% |
10
Processa Pharmaceuticals Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.88 | $0.88 | $0.88 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 03, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Jan 12, 2023 | Maxim Group | Buy | Buy | Hold |
Aug 03, 2021 | Oppenheimer | - | Outperform | Initialise |
10
Processa Pharmaceuticals Financial Forecast
Processa Pharmaceuticals Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - |
# Analysts | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - |
Forecast
Processa Pharmaceuticals EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - |
Forecast
Processa Pharmaceuticals Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - | - |
Avg Forecast | $-1.57M | $-1.54M | $-1.80M | $-2.16M | $-2.49M | $-3.28M | $-3.01M |
High Forecast | $-1.57M | $-1.54M | $-1.80M | $-2.16M | $-2.49M | $-3.28M | $-3.01M |
Low Forecast | $-1.57M | $-1.54M | $-1.80M | $-2.16M | $-2.49M | $-3.28M | $-3.01M |
Surprise % | - | - | - | - | - | - | - |
Forecast
Processa Pharmaceuticals SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - |
SG&A | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - |
Forecast
Processa Pharmaceuticals EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - |
Avg Forecast | $-0.48 | $-0.47 | $-0.55 | $-0.66 | $-0.76 | $-1.00 | $-1.01 |
High Forecast | $-0.48 | $-0.47 | $-0.55 | $-0.66 | $-0.76 | $-1.00 | $-1.01 |
Low Forecast | $-0.48 | $-0.47 | $-0.55 | $-0.66 | $-0.76 | $-1.00 | $-1.01 |
Surprise % | - | - | - | - | - | - | - |
Forecast
Processa Pharmaceuticals Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
AKTX | Akari Therapeutics | $1.24 | $12.00K | 967641.94% | - |
PMVP | PMV Pharmaceuticals | $1.61 | $18.00 | 1018.01% | Buy |
PCSA | Processa Pharmaceuticals | $0.88 | $9.00 | 922.73% | Buy |
ANTX | AN2 Therapeutics | $1.23 | $8.75 | 611.38% | Buy |
ANEB | Anebulo Pharmaceuticals | $1.50 | $6.00 | 300.00% | Buy |
FENC | Fennec Pharmaceuticals | $4.72 | $15.75 | 233.69% | Buy |
IKT | Inhibikase Therapeutics | $2.01 | $6.50 | 223.38% | Buy |
ELYM | Eliem Therapeutics | $5.11 | $13.00 | 154.40% | Buy |
CELC | Celcuity | $12.73 | $31.50 | 147.45% | Buy |
SABS | SAB Biotherapeutics | $3.07 | $5.67 | 84.69% | Buy |
ELVN | Enliven Therapeutics | $25.41 | $39.50 | 55.45% | Buy |
THRD | Third Harmonic Bio | $11.45 | $16.15 | 41.05% | Buy |